Gastroenterology
Volume 139, Issue 2 , Pages 632-643.e4 , August 2010

C/EBPα Is Up-regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation

  • Guo–Dong Lu

      Affiliations

    • Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Carol Ho–Wing Leung

      Affiliations

    • Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Benedict Yan

      Affiliations

    • Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Colyn Mui–Yeong Tan

      Affiliations

    • Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Sie Yieh Low

      Affiliations

    • Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Myat Oo Aung

      Affiliations

    • Department of Medicine, National University Hospital Health Systems, Singapore
    • ,
  • Manuel Salto–Tellez

      Affiliations

    • Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • Seng Gee Lim

      Affiliations

    • Department of Medicine, National University Hospital Health Systems, Singapore
    • ,
  • Shing Chuan Hooi

      Affiliations

    • Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • Corresponding Author InformationReprint requests Address requests for reprints to: Dr Shing Chuan Hooi, Department of Physiology, National University of Singapore, Singapore. Blk MD9, 2 Medical Drive, Singapore 117597. fax: (65) 6778-8161

Received 3 August 2009 ,Accepted 18 March 2010.

References 

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576
  2. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol. 2008;14:1652–1656
  3. Schuster MB, Porse BT. C/EBPalpha: a tumour suppressor in multiple tissues?. Biochim Biophys Acta. 2006;1766:88–103
  4. Nerlov C. C/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer. 2004;4:394–400
  5. Marcucci G, Maharry K, Radmacher MD, et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol. 2008;26:5078–5087
  6. Chapiro E, Russell L, Radford-Weiss I, et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood. 2006;108:3560–3563
  7. Yin H, Lowery M, Glass J. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT. Prostate. 2009;69:1001–1016
  8. Tan EH, Hooi SC, Laban M, et al. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Cancer Res. 2005;65:10330–10337
  9. Watanabe T, Morizane T, Tsuchimoto K, et al. Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma. Int J Cancer. 1983;32:141–146
  10. Plumb JA, Finn PW, Williams RJ, et al. Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101. Mol Cancer Ther. 2003;2:721–728
  11. Lu GD, Shen HM, Ong CN, et al. Anticancer effects of aloe-emodin on HepG2 cells: cellular and proteomic studies. Proteomics Clin Appl. 2007;1:410–419
  12. Qiu GH, Xie H, Wheelhouse N, et al. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol. 2007;46:655–663
  13. Wang GL, Iakova P, Wilde M, et al. Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes Dev. 2004;18:912–925
  14. Waxman S, Wurmbach E. De-regulation of common housekeeping genes in hepatocellular carcinoma. BMC Genomics. 2007;8:243
  15. Herbst RS, Friedman N, Darnell JE, et al. Positive and negative regulatory elements in the mouse albumin enhancer. Proc Natl Acad Sci U S A. 1989;86:1553–1557
  16. Li HM, Ikeda H, Nakabayashi H, et al. Identification of CCAAT enhancer binding protein alpha binding sites on the human alpha-fetoprotein gene. Gene. 2007;389:128–135
  17. Resnitzky D, Hengst L, Reed SI. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol. 1995;15:4347–4352
  18. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672–1677
  19. Wang GL, Timchenko NA. Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein. Mol Cell Biol. 2005;25:1325–1338
  20. Tomizawa M, Watanabe K, Saisho H, et al. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker. Anticancer Res. 2003;23:351–354
  21. Datta J, Majumder S, Kutay H, et al. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. Cancer Res. 2007;67:2736–2746
  22. Tseng HH, Hwang YH, Yeh KT, et al. Reduced expression of C/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival. J Cancer Res Clin Oncol. 2009;135:241–247
  23. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27:263–270
  24. Tada Y, Brena RM, Hackanson B, et al. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst. 2006;98:396–406
  25. Bennett KL, Hackanson B, Smith LT, et al. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res. 2007;67:4657–4664
  26. Makki MS, Heinzel T, Englert C. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. Nucleic Acids Res. 2008;36:4067–4078
  27. Ferguson M, Henry PA, Currie RA. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. Nucleic Acids Res. 2003;31:3123–3133

 Conflicts of interest The authors disclose no conflicts.

 Funding This work is supported by grants from the Singapore National Medical Research Council (NMRC/1068/2006 and NMRC/1211/2009).

PII: S0016-5085(10)00484-1

doi: 10.1053/j.gastro.2010.03.051

Gastroenterology
Volume 139, Issue 2 , Pages 632-643.e4 , August 2010

Article Tools

* Image Usage & Resolution